Islet transplant model in nonhuman primates: use of streptozotocin

Transplantation Reviews

Volumn 20, Issue 3, 2006, Pages 126-130

  Koulmanda, Maria ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; STREPTOZOCIN;

ARTICLE; CLINICAL PROTOCOL; DISEASE MODEL; EXPERIMENTAL MODEL; GRAFT SURVIVAL; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; LABORATORY TEST; MEDICAL DECISION MAKING; NONHUMAN; ORGAN DONOR; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; PANCREAS TRANSPLANTATION; PRIMATE; RELIABILITY; STREPTOZOCIN DIABETES; TREATMENT OUTCOME;

EID: 33747753803     PISSN: 0955470X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trre.2006.06.003     Document Type: Article

References (22)

1. Sun Y., Ma X., Zhou D., Vacek I., and Sun A.M. Normalization of diabetes in spontaneously diabetic cynomolgus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. J Clin Invest 98 6 (1996) 1417-1422
2. Howard Jr. C.F. Nonhuman primates as models for the study of human diabetes mellitus. Diabetes 31 Suppl 1 Pt 2 (1982) 37-42
3. Koulmanda M., Qipo A., Chebrolu S., O'Neil J., Auchincloss H., and Smith R.N. The effect of low versus high dose of streptozotocin in cynomolgus monkeys (Macaca fascilularis). Am J Transplant 3 3 (2003) 267-272
4. Stegall M.D., Chabot J., Weber C., Reemtsma K., and Hardy M.A. Pancreatic islet transplantation in cynomolgus monkeys. Initial studies and evidence that cyclosporine impairs glucose tolerance in normal monkeys. Transplantation 48 6 (1989) 944-950
5. Kenyon N.S., Chatzipetrou M., Masetti M., Ranuncoli A., Oliveira M., Wagner J.L., et al. Long-term survival and function of intrahepatic islet allografts in rhesus monkeys treated with humanized anti-CD154. Proc Natl Acad Sci U S A 96 14 (1999) 8132-8137
6. Ranuncoli A., Cautero N., Ricordi C., Masetti M., Molano R.D., Inverardi L., et al. Islet cell transplantation: in vivo and in vitro functional assessment of nonhuman primate pancreatic islets. Cell Transplant 9 3 (2000) 409-414
7. Dufrane D., van Steenberghe M., Guiot Y., Goebbels R.M., Saliez A., and Gianello P. Streptozotocin-induced diabetes in large animals (pigs/primates): role of GLUT2 transporter and beta-cell plasticity. Transplantation 81 1 (2006) 36-45
8. Tal M.G., Hirshberg B., Neeman Z., Bunnell D., Soleimanpour S., Bacher J., et al. Induction of diabetes in nonhuman primates by means of temporary arterial embolization and selective arterial injection of streptozotocin. Radiology 230 1 (2004) 163-168
9. Wijkstrom M., Kirchhof N., Graham M., Ingulli E., Colvin R.B., Christians U., et al. Cyclosporine toxicity in immunosuppressed streptozotocin-diabetic nonhuman primates. Toxicology 207 1 (2005) 117-127
10. Theriault B.R., Thistlethwaite Jr. J.R., Levisetti M.G., Wardrip C.L., Szot G., Bruce D.S., et al. Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascilularis). Transplantation 68 3 (1999) 331-337
11. Schnedl W.J., Ferber S., Johnson J.H., and Newgard C.B. STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells. Diabetes 43 11 (1994) 1326-1333
12. Pitkin R.M., and Reynolds W.A. Diabetogenic effects of streptozotocin in rhesus monkeys. Diabetes 19 2 (1970) 85-90
13. Jonasson O., Jones C.W., Bauman A., John E., Manaligod J., and Tso M.O. The pathophysiology of experimental insulin-deficient diabetes in the monkey. Implications for pancreatic transplantation. Ann Surg 201 1 (1985) 27-39
14. Ericzon B.G., Wijnen R.M., Kubota K., vd Bogaard A., and Kootstra G. Diabetes induction and pancreatic transplantation in the cynomolgus monkey: methodological considerations. Transpl Int 4 2 (1991) 103-109
15. Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50 6 (2001) 537-546
16. Voss C., Brachmann K., and Hartmann K. Effect of streptozotocin on transaminases, creatinine and urea in serum of rats. Exp Clin Endocrinol 92 1 (1988) 37-42
17. Bonner-Weir S. Perspective: postnatal pancreatic beta cell growth. Endocrinology 141 6 (2000) 1926-1929
18. Kemnitz J.W., Perelman R.H., Engle M.J., and Farrell P.M. An experimental model for studies of fetal maldevelopment in the diabetic pregnancy. Pediatr Pulmonol 1 3 Suppl (1985) S79-S85
19. Gaur L.K., Nepom G.T., and Lernmark A. Low-dose streptozotocin induces sustained hyperglycemia in Macaca nemestrina. Autoimmunity 33 2 (2001) 103-114
20. Litwak K.N., Cefalu W.T., and Wagner J.D. Streptozotocin-induced diabetes mellitus in cynomolgus monkeys: changes in carbohydrate metabolism, skin glycation, and pancreatic islets. Lab Anim Sci 48 2 (1998) 172-178
21. Tuch B.E., Turtle J.R., and Simeonovic C.J. Streptozotocin is not toxic to the human fetal B cell. Diabetologia 32 9 (1989) 678-684
22. Liu X.M., Federlin K.F., Bretzel R.G., Hering B.J., and Brendel M.D. Persistent reversal of diabetes by transplantation of fetal pig proislets into nude mice. Diabetes 40 7 (1991) 858-866